Human leukemia inhibitory factor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 22, 1995
Issued Date -
N/A
app pub date -
Sep 22, 1992
filing date -
Apr 2, 1987
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Leukemia-inhibitory factor (LIF) has been produced in essentially pure form from murine or human sources. A method of purifying this LIF is disclosed, as well as polypeptides having LIF activity which are not identical in amino acid sequence to any naturally occurring form of LIF. The polypeptides can be used for hindering the proliferation of myeloid Leukemia cells.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully